| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 6.10B | — |
| Operating expense | — | — |
| Net income | 1.77B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CAPLIPOINT.NS returned +18.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +39.6% |
| 1 year | +18.5% |
| 5 years | +248.7% |
| 10 years | +982.2% |
| All-time high | ₹2,626.00 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in CAPLIPOINT.NS would be worth today ›Yes. Caplin Point Laboratories Limited paid 2 dividends over the past 12 months. The most recent was ₹4.00 per share on May 29, 2026. The dividend yield is 0.31%.
Caplin Point Laboratories Limited is part of the Healthcare sector.
Caplin Point Laboratories Limited has a market cap of 189.73B INR, based on the latest quote.
